Almac’s Clinical Services business unit has expanded its service offering for dispensing and bottling solid dosage products by introducing enhanced containment equipment and processes at its EU and US headquarters.
Managing Director of Almac Clinical Services Dr. Robert Dunlop commented: “In recent years, we have experienced an increase in demand for facilities equipped to handle compounds of a higher potency. As a customer orientated company, Almac saw an opportunity to meet the needs of its client base. This development at our European and North American Headquarters is the latest example of how Almac constantly strives to advance its service offering to reflect the needs of the drug development industry.”
Following successful installation and validation, the facilities are now operational and Almac welcomes packaging discussions with companies that have potent products in their pipelines.
Almac Group Ltd, +44 28 3833 2200, info@almacgroup.com, www.almacgroup.com.